TEVA
insider transactionsTEVA PHARMACEUTICAL INDUSTRIES LTD — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-2.2M
0 buy · 2.2M sell
Net value · 365d
-$72.5M
$0 in · $72.5M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
32
0 buy · 2.2M sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
EVP, Chief Financial Officer · 10b5-1
$3.6M
106.6K sh · $34.10
Own -62%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +25%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +15%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +14%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +14%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +302%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +13%
-
Exercise·M
President and CEO · 10b5-1
$0
13.0K sh
Own +50%
-
Sell·S
President and CEO · 10b5-1
$211.4K
6.2K sh · $34.35
Own -1%
-
Exercise·M
President and CEO · 10b5-1
—
13.0K sh
Own +1%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +1%
-
Exercise·M
Director
$0
14.5K sh
Own New
-
Exercise·M
Director
—
14.5K sh
Own +13%
-
Exercise·M
Director
$0
21.7K sh
Own New
-
Exercise·M
Director
—
21.7K sh
Own +5%
-
Exercise·M
EVP, Global Operations · 10b5-1
$0
16.2K sh
Own +100%
-
Sell·S
EVP, Global Operations · 10b5-1
$532.3K
16.2K sh · $32.87
Own -62%
-
Exercise·M
EVP, Global Operations · 10b5-1
—
16.2K sh
Own +162%
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
7.2K sh
Own New
-
Grant·A
Director
$0
10.9K sh
Own New
-
Exercise·M
EVP, Business Development · 10b5-1
$0
74.0K sh
Own New
-
Exercise·M
EVP, Business Development · 10b5-1
$0
11.8K sh
Own +50%
-
Sell·S
EVP, Business Development · 10b5-1
$1.3M
35.9K sh · $35.58
Own -45%
-
Exercise·M
EVP, Business Development · 10b5-1
—
74.0K sh
Own +1214%
-
Sell·S
EVP, Business Development · 10b5-1
$204.5K
5.7K sh · $35.58
Own -49%
-
Exercise·M
EVP, Business Development · 10b5-1
—
11.8K sh
Own New
-
Sell·S
EVP, Chief Financial Officer · 10b5-1
$5.5M
153.3K sh · $35.61
Own -47%
-
Sell·S
Chief Accounting Officer
$384.4K
10.7K sh · $36.00
Own -35%
-
Sell·S
EVP, Europe Commercial
$1.1M
30.0K sh · $35.40
Own -35%
-
Sell·S
See "Remarks"
$5.0M
144.2K sh · $34.99
Own -64%
-
Sell·S
EVP, U.S. Commercial
$750.6K
21.3K sh · $35.31
Own -25%
-
Sell·S
See "Remarks"
$1.9M
62.1K sh · $30.14
Own -22%
-
Exercise·M
Chief Accounting Officer
$0
3.5K sh
Own +50%
-
Exercise·M
Chief Accounting Officer
—
3.5K sh
Own +13%
-
Exercise·M
EVP, Global Operations · 10b5-1
$0
17.3K sh
Own +50%
-
Sell·S
EVP, Global Operations · 10b5-1
$547.7K
17.3K sh · $31.67
Own -63%
-
Exercise·M
EVP, Global Operations · 10b5-1
—
17.3K sh
Own +173%
-
Exercise·M
Interim Chief Legal Officer
$0
3.6K sh
Own +50%
-
Sell·S
Interim Chief Legal Officer
$35.7K
1.1K sh · $31.67
Own -9%
-
Exercise·M
Interim Chief Legal Officer
—
3.6K sh
Own +42%
-
Exercise·M
See "Remarks"
$0
15.7K sh
Own +50%
-
Exercise·M
See "Remarks"
—
15.7K sh
Own +6%
-
Exercise·M
EVP, Chief Financial Officer
$0
19.9K sh
Own +50%
-
Exercise·M
EVP, Chief Financial Officer
—
19.9K sh
Own +7%
-
Exercise·M
See "Remarks" · 10b5-1
$0
14.2K sh
Own +50%
-
Sell·S
See "Remarks" · 10b5-1
$448.1K
14.2K sh · $31.67
Own -68%
-
Exercise·M
See "Remarks" · 10b5-1
—
14.2K sh
Own +209%
-
Exercise·M
President and CEO · 10b5-1
$0
42.5K sh
Own +50%
-
Sell·S
President and CEO · 10b5-1
$634.2K
20.0K sh · $31.67
Own -2%
-
Exercise·M
President and CEO · 10b5-1
—
42.5K sh
Own +4%
-
Exercise·M
EVP, U.S. Commercial · 10b5-1
$0
17.8K sh
Own +50%
-
Sell·S
EVP, U.S. Commercial · 10b5-1
$250.9K
7.9K sh · $31.67
Own -9%
-
Exercise·M
EVP, U.S. Commercial · 10b5-1
—
17.8K sh
Own +24%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
$0
17.3K sh
Own +50%
-
Sell·S
EVP, Europe Commercial · 10b5-1
$547.7K
17.3K sh · $31.67
Own -17%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
—
17.3K sh
Own +20%
-
Grant·A
Chief Accounting Officer
$0
11.3K sh
Own New
-
Exercise·M
Chief Accounting Officer
$0
5.7K sh
Own +100%
-
Exercise·M
Chief Accounting Officer
$0
10.7K sh
Own New
-
Exercise·M
Chief Accounting Officer
—
5.7K sh
Own +26%
-
Exercise·M
Chief Accounting Officer
—
10.7K sh
Own +99%
-
Grant·A
EVP, Global Operations
$0
33.4K sh
Own New
-
Grant·A
Interim Chief Legal Officer
$0
11.3K sh
Own New
-
Exercise·M
Interim Chief Legal Officer
$0
3.8K sh
Own +100%
-
Exercise·M
Interim Chief Legal Officer
$0
4.7K sh
Own New
-
Sell·S
Interim Chief Legal Officer
$38.5K
1.2K sh · $32.46
Own -12%
-
Exercise·M
Interim Chief Legal Officer
—
3.5K sh
Own +56%
-
Sell·S
Interim Chief Legal Officer
$48.3K
1.5K sh · $32.46
Own -19%
-
Exercise·M
Interim Chief Legal Officer
—
4.7K sh
Own +162%
-
Grant·A
See "Remarks"
$0
30.4K sh
Own New
-
Exercise·M
See "Remarks"
$0
18.6K sh
Own +100%
-
Exercise·M
See "Remarks"
$0
33.5K sh
Own New
-
Exercise·M
See "Remarks"
—
18.6K sh
Own +7%
-
Exercise·M
See "Remarks"
—
33.5K sh
Own +15%
-
Grant·A
EVP, Business Development
$0
27.3K sh
Own New
-
Grant·A
EVP, Chief Financial Officer
$0
53.2K sh
Own New
-
Exercise·M
EVP, Chief Financial Officer
$0
23.3K sh
Own +100%
-
Exercise·M
EVP, Chief Financial Officer
$0
33.5K sh
Own New
-
Exercise·M
EVP, Chief Financial Officer
—
23.3K sh
Own +8%
-
Exercise·M
EVP, Chief Financial Officer
—
33.5K sh
Own +13%
-
Grant·A
See "Remarks"
$0
38.0K sh
Own New
-
Grant·A
President and CEO · 10b5-1
$0
136.7K sh
Own New
-
Exercise·M
President and CEO · 10b5-1
$0
50.2K sh
Own +100%
-
Sell·S
President and CEO · 10b5-1
$759.4K
23.4K sh · $32.46
Own -2%
-
Exercise·M
President and CEO · 10b5-1
—
50.2K sh
Own +4%
-
Grant·A
EVP, U.S. Commercial · 10b5-1
$0
50.6K sh
Own New
-
Exercise·M
EVP, U.S. Commercial · 10b5-1
$0
20.5K sh
Own +100%
-
Sell·S
EVP, U.S. Commercial · 10b5-1
$295.4K
9.1K sh · $32.46
Own -11%
-
Exercise·M
EVP, U.S. Commercial · 10b5-1
—
20.5K sh
Own +32%
-
Grant·A
EVP, Europe Commercial · 10b5-1
$0
33.4K sh
Own New
-
Exercise·M
EVP, Europe Commercial · 10b5-1
$0
20.5K sh
Own +100%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
$0
33.5K sh
Own New
-
Sell·S
EVP, Europe Commercial · 10b5-1
$1.2M
37.4K sh · $32.95
Own -30%
-
Sell·S
EVP, Europe Commercial · 10b5-1
$664.3K
20.5K sh · $32.46
Own -14%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
—
20.5K sh
Own +17%
-
Sell·S
EVP, Europe Commercial · 10b5-1
$1.1M
33.5K sh · $32.46
Own -21%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
—
33.5K sh
Own +27%
-
Exercise·M
Chief Accounting Officer
$0
5.2K sh
Own +517900%
-
Exercise·M
Chief Accounting Officer
—
5.2K sh
Own +92%
-
Exercise·M
Interim Chief Legal Officer
$0
3.5K sh
Own New
-
Sell·S
Interim Chief Legal Officer
$41.2K
1.3K sh · $32.36
Own -30%
-
Exercise·M
Interim Chief Legal Officer
—
3.5K sh
Own +468%
-
Exercise·M
See "Remarks"
$0
141.5K sh
Own New
-
Exercise·M
See "Remarks"
$0
24.9K sh
Own +2490000%
-
Exercise·M
See "Remarks"
—
141.5K sh
Own +182%
-
Exercise·M
See "Remarks"
—
24.9K sh
Own +47%
-
Exercise·M
EVP, Chief Financial Officer
$0
141.5K sh
Own New
-
Exercise·M
EVP, Chief Financial Officer
$0
49.8K sh
Own +2490000%
-
Exercise·M
EVP, Chief Financial Officer
—
141.5K sh
Own +132%
-
Exercise·M
EVP, Chief Financial Officer
—
49.8K sh
Own +87%
-
Exercise·M
President and CEO · 10b5-1
$0
891.3K sh
Own New
-
Exercise·M
President and CEO · 10b5-1
$0
67.2K sh
Own New
-
Sell·S
President and CEO · 10b5-1
$13.3M
412.0K sh · $32.36
Own -27%
-
Exercise·M
President and CEO · 10b5-1
—
891.3K sh
Own +139%
-
Sell·S
President and CEO · 10b5-1
$1.0M
30.9K sh · $32.36
Own -5%
-
Exercise·M
President and CEO · 10b5-1
—
67.2K sh
Own +11%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
$0
141.5K sh
Own New
-
Exercise·M
EVP, Europe Commercial · 10b5-1
$0
62.2K sh
Own +2075000%
-
Sell·S
EVP, Europe Commercial · 10b5-1
$2.2M
66.7K sh · $32.36
Own -35%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
—
141.5K sh
Own +292%
-
Sell·S
EVP, Europe Commercial · 10b5-1
$2.0M
62.2K sh · $32.36
Own -56%
-
Exercise·M
EVP, Europe Commercial · 10b5-1
—
62.2K sh
Own +129%
-
Sell·S
EVP, Chief Financial Officer · 10b5-1
$11.6M
345.8K sh · $33.64
Own -86%
-
Exercise·M
President and CEO · 10b5-1
$0
620.1K sh
Own New
-
Exercise·M
President and CEO · 10b5-1
$0
161.7K sh
Own New
-
Sell·S
President and CEO · 10b5-1
$9.8M
286.1K sh · $34.22
Own -32%
-
Exercise·M
President and CEO · 10b5-1
—
620.1K sh
Own +228%
-
Sell·S
President and CEO · 10b5-1
$5.5M
161.7K sh · $34.22
Own -37%
-
Exercise·M
President and CEO · 10b5-1
—
161.7K sh
Own +59%
-
Grant·A
See "Remarks"
$0
141.5K sh
Own New
-
Grant·A
EVP, Chief Financial Officer
$0
141.5K sh
Own New
-
Grant·A
President and CEO
$0
891.3K sh
Own New
-
Grant·A
President and CEO
$0
620.1K sh
Own New
-
Grant·A
Exec. VP, European Commercial
$0
141.5K sh
Own New
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Eliyahu Sharon Kalif KEY 10b5-1 | Sell S | 106.6K | $3.6M |
| Jun 5, 2026 | Tal Zvi Zaks | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Tal Zvi Zaks | Exercise M | 14.5K | — |
| Jun 5, 2026 | Ronit Satchi-Fainaro | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Ronit Satchi-Fainaro | Exercise M | 14.5K | — |
| Jun 5, 2026 | Perry Nisen | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Perry Nisen | Exercise M | 14.5K | — |
| Jun 5, 2026 | Roberto Mignone | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Roberto Mignone | Exercise M | 14.5K | — |
| Jun 5, 2026 | Chen Lichtenstein | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Chen Lichtenstein | Exercise M | 14.5K | — |
| Jun 5, 2026 | Gerald M Lieberman | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Gerald M Lieberman | Exercise M | 14.5K | — |
| Jun 5, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 13.0K | $0 |
| Jun 5, 2026 | Richard D Francis KEY 10b5-1 | Sell S | 6.2K | $211.4K |
| Jun 5, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 13.0K | — |
| Jun 5, 2026 | Amir Elstein | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Amir Elstein | Exercise M | 14.5K | — |
| Jun 5, 2026 | Rosemary A Crane | Exercise M | 14.5K | $0 |
| Jun 5, 2026 | Rosemary A Crane | Exercise M | 14.5K | — |
| Jun 5, 2026 | Sol J Barer | Exercise M | 21.7K | $0 |
| Jun 5, 2026 | Sol J Barer | Exercise M | 21.7K | — |
| Jun 3, 2026 | Matthew Shields 10b5-1 | Exercise M | 16.2K | $0 |
| Jun 3, 2026 | Matthew Shields 10b5-1 | Sell S | 16.2K | $532.3K |
| Jun 3, 2026 | Matthew Shields 10b5-1 | Exercise M | 16.2K | — |
| May 28, 2026 | Tal Zvi Zaks | Grant A | 7.2K | $0 |
| May 28, 2026 | Ronit Satchi-Fainaro | Grant A | 7.2K | $0 |
| May 28, 2026 | Perry Nisen | Grant A | 7.2K | $0 |
| May 28, 2026 | Roberto Mignone | Grant A | 7.2K | $0 |
| May 28, 2026 | Chen Lichtenstein | Grant A | 7.2K | $0 |
| May 28, 2026 | Gerald M Lieberman | Grant A | 7.2K | $0 |
| May 28, 2026 | Amir Elstein | Grant A | 7.2K | $0 |
| May 28, 2026 | Rosemary A Crane | Grant A | 7.2K | $0 |
| May 28, 2026 | Sol J Barer | Grant A | 10.9K | $0 |
| May 14, 2026 | Evan Lippman 10b5-1 | Exercise M | 74.0K | $0 |
| May 14, 2026 | Evan Lippman 10b5-1 | Exercise M | 11.8K | $0 |
| May 14, 2026 | Evan Lippman 10b5-1 | Sell S | 35.9K | $1.3M |
| May 14, 2026 | Evan Lippman 10b5-1 | Exercise M | 74.0K | — |
| May 14, 2026 | Evan Lippman 10b5-1 | Sell S | 5.7K | $204.5K |
| May 14, 2026 | Evan Lippman 10b5-1 | Exercise M | 11.8K | — |
| May 14, 2026 | Eliyahu Sharon Kalif KEY 10b5-1 | Sell S | 153.3K | $5.5M |
| May 6, 2026 | Amir Weiss | Sell S | 10.7K | $384.4K |
| May 5, 2026 | Richard Daniell | Sell S | 30.0K | $1.1M |
| May 1, 2026 | Mark Sabag | Sell S | 144.2K | $5.0M |
| Apr 30, 2026 | Christine Fox | Sell S | 21.3K | $750.6K |
| Mar 17, 2026 | Mark Sabag | Sell S | 62.1K | $1.9M |
| Mar 5, 2026 | Amir Weiss | Exercise M | 3.5K | $0 |
| Mar 5, 2026 | Amir Weiss | Exercise M | 3.5K | — |
| Mar 5, 2026 | Matthew Shields 10b5-1 | Exercise M | 17.3K | $0 |
| Mar 5, 2026 | Matthew Shields 10b5-1 | Sell S | 17.3K | $547.7K |
| Mar 5, 2026 | Matthew Shields 10b5-1 | Exercise M | 17.3K | — |
| Mar 5, 2026 | Brian Savage | Exercise M | 3.6K | $0 |
| Mar 5, 2026 | Brian Savage | Sell S | 1.1K | $35.7K |
| Mar 5, 2026 | Brian Savage | Exercise M | 3.6K | — |
| Mar 5, 2026 | Mark Sabag | Exercise M | 15.7K | $0 |
| Mar 5, 2026 | Mark Sabag | Exercise M | 15.7K | — |
| Mar 5, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 19.9K | $0 |
| Mar 5, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 19.9K | — |
| Mar 5, 2026 | Placid Jover 10b5-1 | Exercise M | 14.2K | $0 |
| Mar 5, 2026 | Placid Jover 10b5-1 | Sell S | 14.2K | $448.1K |
| Mar 5, 2026 | Placid Jover 10b5-1 | Exercise M | 14.2K | — |
| Mar 5, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 42.5K | $0 |
| Mar 5, 2026 | Richard D Francis KEY 10b5-1 | Sell S | 20.0K | $634.2K |
| Mar 5, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 42.5K | — |
| Mar 5, 2026 | Christine Fox 10b5-1 | Exercise M | 17.8K | $0 |
| Mar 5, 2026 | Christine Fox 10b5-1 | Sell S | 7.9K | $250.9K |
| Mar 5, 2026 | Christine Fox 10b5-1 | Exercise M | 17.8K | — |
| Mar 5, 2026 | Richard Daniell 10b5-1 | Exercise M | 17.3K | $0 |
| Mar 5, 2026 | Richard Daniell 10b5-1 | Sell S | 17.3K | $547.7K |
| Mar 5, 2026 | Richard Daniell 10b5-1 | Exercise M | 17.3K | — |
| Mar 4, 2026 | Amir Weiss | Grant A | 11.3K | $0 |
| Mar 4, 2026 | Amir Weiss | Exercise M | 5.7K | $0 |
| Mar 4, 2026 | Amir Weiss | Exercise M | 10.7K | $0 |
| Mar 4, 2026 | Amir Weiss | Exercise M | 5.7K | — |
| Mar 4, 2026 | Amir Weiss | Exercise M | 10.7K | — |
| Mar 4, 2026 | Matthew Shields | Grant A | 33.4K | $0 |
| Mar 4, 2026 | Brian Savage | Grant A | 11.3K | $0 |
| Mar 4, 2026 | Brian Savage | Exercise M | 3.8K | $0 |
| Mar 4, 2026 | Brian Savage | Exercise M | 4.7K | $0 |
| Mar 4, 2026 | Brian Savage | Sell S | 1.2K | $38.5K |
| Mar 4, 2026 | Brian Savage | Exercise M | 3.5K | — |
| Mar 4, 2026 | Brian Savage | Sell S | 1.5K | $48.3K |
| Mar 4, 2026 | Brian Savage | Exercise M | 4.7K | — |
| Mar 4, 2026 | Mark Sabag | Grant A | 30.4K | $0 |
| Mar 4, 2026 | Mark Sabag | Exercise M | 18.6K | $0 |
| Mar 4, 2026 | Mark Sabag | Exercise M | 33.5K | $0 |
| Mar 4, 2026 | Mark Sabag | Exercise M | 18.6K | — |
| Mar 4, 2026 | Mark Sabag | Exercise M | 33.5K | — |
| Mar 4, 2026 | Evan Lippman | Grant A | 27.3K | $0 |
| Mar 4, 2026 | Eliyahu Sharon Kalif KEY | Grant A | 53.2K | $0 |
| Mar 4, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 23.3K | $0 |
| Mar 4, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 33.5K | $0 |
| Mar 4, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 23.3K | — |
| Mar 4, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 33.5K | — |
| Mar 4, 2026 | Placid Jover | Grant A | 38.0K | $0 |
| Mar 4, 2026 | Richard D Francis KEY 10b5-1 | Grant A | 136.7K | $0 |
| Mar 4, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 50.2K | $0 |
| Mar 4, 2026 | Richard D Francis KEY 10b5-1 | Sell S | 23.4K | $759.4K |
| Mar 4, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 50.2K | — |
| Mar 4, 2026 | Christine Fox 10b5-1 | Grant A | 50.6K | $0 |
| Mar 4, 2026 | Christine Fox 10b5-1 | Exercise M | 20.5K | $0 |
| Mar 4, 2026 | Christine Fox 10b5-1 | Sell S | 9.1K | $295.4K |
| Mar 4, 2026 | Christine Fox 10b5-1 | Exercise M | 20.5K | — |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Grant A | 33.4K | $0 |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Exercise M | 20.5K | $0 |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Exercise M | 33.5K | $0 |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Sell S | 37.4K | $1.2M |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Sell S | 20.5K | $664.3K |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Exercise M | 20.5K | — |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Sell S | 33.5K | $1.1M |
| Mar 4, 2026 | Richard Daniell 10b5-1 | Exercise M | 33.5K | — |
| Mar 3, 2026 | Amir Weiss | Exercise M | 5.2K | $0 |
| Mar 3, 2026 | Amir Weiss | Exercise M | 5.2K | — |
| Mar 3, 2026 | Brian Savage | Exercise M | 3.5K | $0 |
| Mar 3, 2026 | Brian Savage | Sell S | 1.3K | $41.2K |
| Mar 3, 2026 | Brian Savage | Exercise M | 3.5K | — |
| Mar 3, 2026 | Mark Sabag | Exercise M | 141.5K | $0 |
| Mar 3, 2026 | Mark Sabag | Exercise M | 24.9K | $0 |
| Mar 3, 2026 | Mark Sabag | Exercise M | 141.5K | — |
| Mar 3, 2026 | Mark Sabag | Exercise M | 24.9K | — |
| Mar 3, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 141.5K | $0 |
| Mar 3, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 49.8K | $0 |
| Mar 3, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 141.5K | — |
| Mar 3, 2026 | Eliyahu Sharon Kalif KEY | Exercise M | 49.8K | — |
| Mar 3, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 891.3K | $0 |
| Mar 3, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 67.2K | $0 |
| Mar 3, 2026 | Richard D Francis KEY 10b5-1 | Sell S | 412.0K | $13.3M |
| Mar 3, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 891.3K | — |
| Mar 3, 2026 | Richard D Francis KEY 10b5-1 | Sell S | 30.9K | $1.0M |
| Mar 3, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 67.2K | — |
| Mar 3, 2026 | Richard Daniell 10b5-1 | Exercise M | 141.5K | $0 |
| Mar 3, 2026 | Richard Daniell 10b5-1 | Exercise M | 62.2K | $0 |
| Mar 3, 2026 | Richard Daniell 10b5-1 | Sell S | 66.7K | $2.2M |
| Mar 3, 2026 | Richard Daniell 10b5-1 | Exercise M | 141.5K | — |
| Mar 3, 2026 | Richard Daniell 10b5-1 | Sell S | 62.2K | $2.0M |
| Mar 3, 2026 | Richard Daniell 10b5-1 | Exercise M | 62.2K | — |
| Feb 26, 2026 | Eliyahu Sharon Kalif KEY 10b5-1 | Sell S | 345.8K | $11.6M |
| Feb 15, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 620.1K | $0 |
| Feb 15, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 161.7K | $0 |
| Feb 15, 2026 | Richard D Francis KEY 10b5-1 | Sell S | 286.1K | $9.8M |
| Feb 15, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 620.1K | — |
| Feb 15, 2026 | Richard D Francis KEY 10b5-1 | Sell S | 161.7K | $5.5M |
| Feb 15, 2026 | Richard D Francis KEY 10b5-1 | Exercise M | 161.7K | — |
| Jan 27, 2026 | Mark Sabag | Grant A | 141.5K | $0 |
| Jan 27, 2026 | Eliyahu Sharon Kalif KEY | Grant A | 141.5K | $0 |
| Jan 27, 2026 | Richard D Francis KEY | Grant A | 891.3K | $0 |
| Jan 27, 2026 | Richard D Francis KEY | Grant A | 620.1K | $0 |
| Jan 27, 2026 | Richard Daniell | Grant A | 141.5K | $0 |
About TEVA insider trading
This page tracks insider transactions for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.